Survey-based study of treatment sequencing after first-line (1L) enfortumab vedotin/pembrolizumab (EVP) in the evolving landscape of locally advanced/metastatic (la/m) urothelial cancer (UC) Meeting Abstract
| Authors: | Chablani, P. V.; Khaki, A. R.; Tawagi, K.; Grivas, P.; Hoffman-Censits, J.; Galsky, M. D.; Gupta, S.; Koshkin, V. S.; Plimack, E. R.; Rosenberg, J. E.; O'Donnell, P. H. |
| Abstract Title: | Survey-based study of treatment sequencing after first-line (1L) enfortumab vedotin/pembrolizumab (EVP) in the evolving landscape of locally advanced/metastatic (la/m) urothelial cancer (UC) |
| Meeting Title: | 2025 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 5 Suppl. |
| Meeting Dates: | 2025 Feb 13-15 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-02-10 |
| Language: | English |
| ACCESSION: | WOS:001454758700042 |
| DOI: | 10.1200/JCO.2025.43.5_suppl.770 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 770 -- Source: Wos |
